Which laboratory values define severe preeclampsia and what is the recommended management?

Laboratory Values Defining Severe Preeclampsia and Management

Monitor hemoglobin, platelet count, liver transaminases, creatinine, and uric acid at least twice weekly in all women with preeclampsia, as these laboratory abnormalities define severe features and guide delivery decisions. 1

Key Laboratory Thresholds for Severe Features

Based on the ISSHP 2018 guidelines and supporting research, the following laboratory values indicate severe preeclampsia:

Critical Laboratory Values:

• Platelets: Progressive thrombocytopenia (particularly <100,000/μL indicates severity) 2
• Liver enzymes:
  • AST >150 IU/L 3
  • ALT >100 IU/L 3
  • AST or ALT >2× upper limit of normal 2
• Creatinine: >1.0 mg/dL 3
• Uric acid: >7.8 mg/dL 3
• LDH: >1400 IU/L 3
• Proteinuria: ≥30 mg/mmol protein/creatinine ratio (≥0.3 mg/mg) 1

Important caveat: Research demonstrates that LDH >1400 IU/L, AST >150 IU/L, and uric acid >7.8 mg/dL have the strongest predictive value for significant maternal morbidity and are risk-additive with worsening thrombocytopenia 3. These thresholds are more clinically useful than the traditional "twice normal" cutoffs.

Laboratory Monitoring Schedule

The ISSHP guidelines mandate a minimum of twice weekly blood testing for all women with preeclampsia, including: 1

• Hemoglobin
• Platelet count
• Liver function tests (AST, ALT)
• Renal function (creatinine)
• Uric acid

Testing should increase in frequency (more than twice weekly) when clinical status changes or laboratory values begin trending abnormally 1.

Recent evidence suggests optimal testing intervals vary by disease severity 4:

• PE with severe features: every 2 days
• PE without severe features: every 4 days
• Superimposed PE with severe features: every 3 days
• Superimposed PE without severe features: every 8 days

Most laboratory abnormalities develop within 10 days of diagnosis, occurring earlier and more frequently in those with severe features 4.

Blood Pressure Criteria

Severe hypertension is defined as BP ≥160/110 mmHg and requires urgent treatment within 60 minutes in a monitored setting 1, 5. This is a critical threshold that mandates immediate intervention regardless of laboratory values.

Management Algorithm Based on Laboratory Results

Immediate Delivery Indications (Any Gestational Age):

Deliver immediately if any of the following laboratory-driven criteria are met 1:

1. Progressive thrombocytopenia (declining platelet counts)
2. Progressively abnormal liver enzyme tests (rising AST/ALT)
3. Progressively abnormal renal function tests (rising creatinine)
4. Pulmonary edema (clinical finding)
5. Severe hypertension refractory to 3 antihypertensive classes
6. Abnormal neurological features (severe headache, visual scotomata, convulsions)
7. Nonreassuring fetal status

Gestational Age-Based Delivery Timing:

• ≥37 weeks: Deliver all women with preeclampsia 1
• 34-37 weeks: Deliver if severe features develop 1
• <34 weeks: Conservative management possible ONLY if:
  • Laboratory values remain stable (not progressively worsening)
  • Blood pressure controlled with medications
  • Fetal biophysical profiles normal
  • Patient in tertiary care center 6

Critical distinction: The guidelines explicitly state "there should be no attempt to diagnose mild versus severe preeclampsia clinically as all cases may become emergencies, often rapidly" 1. This means all preeclampsia requires close laboratory surveillance.

Magnesium Sulfate Prophylaxis

Administer magnesium sulfate for seizure prophylaxis when: 1

• Proteinuria AND severe hypertension (≥160/110 mmHg), OR
• Hypertension with neurological signs or symptoms

In low-resource settings, all women with preeclampsia should receive MgSO₄ prophylaxis 1.

Initial Assessment Requirements

All women with preeclampsia must be assessed in hospital when first diagnosed 1. After initial evaluation, outpatient management is acceptable only if:

• Condition is stable
• Patient reliable for reporting problems
• Patient can monitor BP at home

Laboratory Values NOT Used for Delivery Decisions

Neither serum uric acid level nor the degree of proteinuria should be used as isolated indications for delivery 1. However, uric acid >7.8 mg/dL is associated with worse maternal and fetal outcomes and should trigger increased surveillance 1.

Common Pitfalls to Avoid

1. Don't wait for "severe" laboratory thresholds: Progressive worsening (trending abnormalities) is an indication for delivery, not just absolute values 1

2. Don't rely on single laboratory values: The pattern of change matters more than isolated results 3, 7

3. Don't underestimate clinical symptoms: Nausea/vomiting and epigastric pain are independent risk factors for complicated severe preeclampsia, even with normal labs 3

4. Don't delay testing: Most laboratory abnormalities occur within 10 days of diagnosis; waiting too long between tests risks missing critical changes 4

5. Don't forget postpartum monitoring: Women remain at high risk for preeclamptic complications for at least 3 days postpartum and require BP and clinical monitoring every 4 hours while awake 1